BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15880157)

  • 1. [Assessment of dementia and use of anti-dementia drugs in nursing homes].
    Engedal K
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1188-90. PubMed ID: 15880157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of dementia].
    Engedal K
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):520-4. PubMed ID: 11961983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological treatment in severe dementia].
    Jouanny P; Belliard S; Bentué-Ferrer D; Michel O; Allain H
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing early to late stage dementia: the TSI and BANS-S scales in the nursing-home.
    Appollonio I; Gori C; Riva G; Spiga D; Ferrari A; Ferrarese C; Frattola L
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1138-45. PubMed ID: 16315161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
    Feldman HH; Schmitt FA; Olin JT;
    Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
    Riccio D; Solinas A; Astara G; Mantovani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes.
    Selbaek G; Kirkevold Ø; Engedal K
    Int J Geriatr Psychiatry; 2007 Sep; 22(9):843-9. PubMed ID: 17193341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study.
    Devine ME; Fonseca JA; Walker RW; Sikdar T; Stevens T; Walker Z
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1120-6. PubMed ID: 17457951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric and behavioural symptoms and the use of psychotropic medication in Special Care Units and Regular Units in Norwegian nursing homes.
    Selbaek G; Kirkevold Ø; Engedal K
    Scand J Caring Sci; 2008 Dec; 22(4):568-73. PubMed ID: 18801019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underrecognition and undertreatment of dementia in Italian nursing homes.
    Cherubini A; Ruggiero C; Dell'Aquila G; Eusebi P; Gasperini B; Zengarini E; Cerenzia A; Zuliani G; Guaita A; Lattanzio F
    J Am Med Dir Assoc; 2012 Oct; 13(8):759.e7-13. PubMed ID: 22727993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of dementia: anything new?
    Machado JC; Caramelli P
    Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Geriatric assessment in 3 steps. Often mental decline is not correctly assessed].
    MMW Fortschr Med; 2002 Feb; 144(8):51. PubMed ID: 11910828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.